 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers. 
Read more
|
Latest news
In focus
|
14/10/08 - Antisoma Annual Report and Accounts | |
|
18/09/08 - Preliminary results presentation | |
|
11/06/08 - Antisoma acquires Xanthus |
Share price
| 19.50 GBp |  0.25 |
| Date: | 19/11/2008 |
